seo-company

Light Chain Bioscience | Novimmune SA

NovImmune has successfully divested EmaCo AG, a newly established company owning emapalumab and related assets to Sobi on 18 July 2019. NovImmune SA will continue to operate and focus on its bispecif...load more


Light Chain Bioscience | Novimmune SA's Basic Information

Industry
Headquarters
Switzerland
Founded Year
1998
Headcount
51 - 200 ( View All )
Specialties
Next-generation antibody drug discoveryImmunologyBispecific antibody drugsClinical development

Light Chain Bioscience | Novimmune SA's Competitors

Polish Peptide Laboratory
Polish Peptide Laboratory

Warsaw, Poland

View all employees
Wakonda State Park
Wakonda State Park

View all employees
Geneticure
Geneticure

United States

View all employees
Bioxtal
Bioxtal

France

View all employees

Employee Insights

Employee Function
Employee Location

Light Chain Bioscience | Novimmune SA's Top Employees

people

Franck Gueneau

Research Associate

Phone Email

people

Laurence Chatel

Research Associate

Phone Email

people

Herren Suzanne

Senior Research Associate

Phone Email

people

Soheila Emamzadah

Research Associate

Phone Email

people

Sébastien Calloud

Research Associate IN Phage Display Platform

Phone Email

Find Your Next Customer with Better Data

Get access to over 120 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.

Top-ranked on G2 Crowd

GDPR compliantCancel anytime

Free credits every month!

Frequently Asked Questions Regarding Light Chain Bioscience | Novimmune SA

Where is Light Chain Bioscience | Novimmune SA's headquarter located?
Light Chain Bioscience | Novimmune SA's headquarter are located at Switzerland.
How many employees does Light Chain Bioscience | Novimmune SA have?
Light Chain Bioscience | Novimmune SA has 51 - 200 employees.
What is Light Chain Bioscience | Novimmune SA's official website?
Light Chain Bioscience | Novimmune SA's official website is http://www.lightchainbio.com
What does Light Chain Bioscience | Novimmune SA do?
NovImmune has successfully divested EmaCo AG, a newly established company owning emapalumab and related assets to Sobi on 18 July 2019. NovImmune SA will continue to operate and focus on its bispecif...
What specialty does Light Chain Bioscience | Novimmune SA have?
Next-generation antibody drug discoveryImmunologyBispecific antibody drugsClinical development
Find Leads in 1 Click

Connect with anyone with AroundDeal today!

Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.

✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts